Stockreport

Akers Biosciences Announces Q3 2018 Earnings

AKERS BIOSCIENCES INC COMMON S  (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROF [Read more]